According to Sage Therapeutics 's latest financial reports the company's current revenue (TTM) is $91.06 M. In 2022 the company made a revenue of $7.68 M an increase over the years 2021 revenue that were of $6.3 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $86.45 M | 1024.7% |
2022 | $7.68 M | 21.86% |
2021 | $6.3 M | -99.43% |
2020 | $1.11 B | 16123.06% |
2019 | $6.86 M | -92.39% |
2018 | $90.27 M | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Regulus Therapeutics RGLS | N/A | N/A | ๐บ๐ธ USA |
Intercept Pharmaceuticals
ICPT | $0.31 B | 248.86% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | $3.64 B | 3,902.03% | ๐ฎ๐ช Ireland |
Eagle Pharmaceuticals
EGRX | $0.25 B | 182.82% | ๐บ๐ธ USA |